Human CD83 Antibody

Catalog #: AF2044 Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
AF2044
AF2044-SP

All CD83 Antibodies

Product Details

Supplemental Products

Reviews

Summary Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human CD83 Antibody Summary

Species Reactivity

Human

Specificity

Detects human CD83 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant mouse CD83 is observed.

Source

Polyclonal Goat IgG

Purification

Antigen Affinity-purified

Immunogen

Mouse myeloma cell line NS0-derived recombinant human CD83
Thr20-Ala143
Accession # Q01151

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Applications

Recommended Concentration

Sample

Western Blot

0.1 µg/mL

Recombinant Human CD83 Fc Chimera (Catalog # 2044-CD)

Flow Cytometry

2.5 µg/10⁶ cells

Human monocyte-derived mature dendritic cells treated with LPS, Recombinant Human TNF‑ alpha (Catalog # 210‑TA), and Recombinant Human IL‑1 beta /IL‑1F2 (Catalog # 201-LB)

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD83

Human CD83 is a 40 - 50 kDa member of the Siglec (or sialic-acid-binding immunoglobulin-like lectin) family of transmembrane proteins (1-3). CD83 is synthesized as a type I transmembrane glycoprotein that contains a 125 amino acid (aa) extracellular region, a 22 aa transmembrane segment, and 39 aa cytoplasmic domain. It contains one V type Ig-like domain in the extracellular region with no inhibitory cytoplasmic motif(s). Although in vitro studies suggest CD83 may form membrane-bound covalent homodimers, in vivo this does not appear to be the case (1, 4). In the extracellular region, mouse and human CD83 are 66% aa identical (1, 2, 4, 5). Relative to human, mouse CD83 is 11 aa shorter in its extracellular domain and is expressed as a 30-35 kDa protein (1, 4, 5). Human CD83 is active in the mouse system (4). One alternate splice form has been reported. This leads to a small monomeric soluble form of 74 aa that includes aa’s 20-52 and 164-205 (6, 7). In human, proteolytic cleavage and solubilization of CD83 has also been suggested, and this could lead to dimeric circulating CD83 (4, 6). CD83 is a primary marker for dendritic cells (3, 6, 8). It is also found on B cells (6, 9), neutrophils (10), monocytes, and macrophages (11). Except for dendritic cells, CD83 expression is often transient. CD83 binds to sialic acids on target cells (12). The function of CD83 is only now becoming clear. Membrane CD83 appears to promote T cell proliferation, particularly of CD8⁺ cytotoxic T cells (13, 14). Soluble CD83, however, appears to be immunosuppressive and blocks T cell activation (15, 16). On monocytes, CD83 is suggested to drive monocytes into a fibrocyte phenotype (13). A lack of membrane-expressed CD83 leads to an unusual IL-4/IL-10 producing CD4⁺ T cell phenotype (17).

References

Zhou, L-J. et al. (1992) J. Immunol. 149:735.
Kozlow, E.J. et al. (1993) Blood 81:454.
Fujimoto, Y and T.F. Tedder (2006) J. Med. Dent. Sci. 53:85.
Lechmann, M. et al. (2005) Biochem. Biophys. Res. Commun. 329:132.
Berchtold, S. et. al. (1999) FEBS Lett. 461:211.
Hock, B.D. et al. (2001) Int. Immunol. 13:959.
Dudziak, D. et al. (2005) J. Immunol. 174:6672.
Velten, F.W. et al. (2007) Mol. Immunol. 44:1544.
Cramer, S.O. et al. (2000) Int. Immunol. 12:1347.
Yamashiro, S. et al. (2000) Blood 96:3958.
Cao, W. et al. (2005) Biochem. J. 385:85.
Scholler, N. et al. (2001) J. Immunol. 166:3865.
Scholler, N. et al. (2002) J. Immunol. 168:2599.
Hirano, N. et al. (2006) Blood 107:1528.
Kotzor, N. et al. (2004) Immunobiology 209:129.
Zinser, E. et al. (2006) Immunobiology 211:449.
Garcia-Martinez, L.F. et al. (2004) J. Immunol. 173:2995.

Entrez Gene IDs

9308 (Human); 12522 (Mouse)

Alternate Names

B-cell activation protein; BL11; BL11CD83 antigen; CD83 antigen (activated B lymphocytes, immunoglobulin superfamily); CD83 molecule; CD83; Cell surface protein HB15; cell-surface glycoprotein; HB15; HB15hCD83